Immunotherapy revolutionises cancer treatment by harnessing the immune system, offering targeted therapy with fewer side ...

IgGenix, Inc., a clinical-stage biotechnology company pioneering innovative treatments for immune-mediated diseases, today announced the upcoming presentation of new data at the 2025 American Academy ...

Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...

About 5% of people who catch COVID have long-lasting symptoms. In these people, loss of smell, dizziness, fatigue and other hallmark COVID symptoms can persist for months after the initial illness.

Researchers explore the cellular and molecular adaptations associated with human secondary lymphoid tissue in adults during ...

LIG4 syndrome is an exceptionally rare disorder caused by a genetic mutation that prevents the body from repairing damaged ...

Lung transplant recipients are highly susceptible to infection, the researchers noted, and P. aeruginosa is a leading cause ...

Ann LaCasce, MD, MMSc, director of the Dana-Farber/Massachusetts General Brigham Fellowship in Hematology/Oncology, highlights the role of bispecific antibodies in lymphoma research.

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Should you take a vitamin B complex supplement with all eight B vitamins or a supplement with B12 alone? This article helps ...

Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...

“The discovery that memory B cells and antibodies specific to [Nipah] persist 20 years post-infection suggests that vaccines aiming to induce long-term immunity are feasible,” said Dr Hui Ming ...